Key Segmentation
By Technology
-
Polymerase Chain Reaction (PCR)
-
Next-Generation Sequencing (NGS)
-
Microarrays
-
In-Situ Hybridization (FISH / CISH)
-
Sanger Sequencing & Others
By Application
-
Oncology (Cancer Diagnostics)
-
Infectious Disease Testing
-
Genetic Disorder Screening
-
Prenatal & Newborn Screening
-
Forensic & Ancestry Testing
-
Others
By End User
-
Hospitals & Clinics
-
Diagnostic Laboratories
-
Pharmaceutical & Biotechnology Companies
-
Academic & Research Institutes
-
Forensic Laboratories
By Test Type
-
Diagnostic Testing
-
Carrier Testing
-
Predictive & Presymptomatic Testing
-
Prenatal Testing
-
Newborn Screening
By Sample Type
-
Blood Samples
-
Saliva Samples
-
Tissue Samples
-
Buccal Swabs
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated with a 45.04% share in 2025, while Asia-Pacific is the fastest-growing region, expected to expand at a CAGR of 9.19% during 2026–2035.
Polymerase Chain Reaction (PCR) dominated with a 38.55% share in 2025, while Next-Generation Sequencing (NGS) are also projected to grow at the fastest CAGR of 9.34% during 2026–2035.
Growth is driven by rising prevalence of genetic and chronic diseases, increasing adoption of precision medicine, and rapid expansion of next-generation sequencing (NGS) and PCR-based diagnostic technologies.
The market is valued at USD 19.24 Billion in 2025 and is projected to reach USD 40.84 Billion by 2035.
The DNA Diagnostics Market is projected to grow at a CAGR of 8.04% during 2026–2035.